Searchable abstracts of presentations at key conferences in endocrinology

ea0070aep1061 | Hot topics (including COVID-19) | ECE2020

The first case report of Pembrolizumab inducing thyroiditis and hypophysitis

Abdel Rahman Maraqa Sima , McMahon Robert , Pinjala Anusha , Arce Gastelum Alheli , Zena Mohsen

Pembrolizumab is a monoclonal antibody (ab) that exerts antineoplastic effects by inhibiting the immunoevasive effects PD-1 grants cancer cells. It’s used to treat several forms of cancer, including melanoma and non-small cell lung cancer. Despite the promise pembrolizumab has demonstrated, it has been associated with immune-related adverse events. In this report, we describe the first case of both thyroiditis and hypophysitis occurring during active pembrolizumab t...